Study: Telehealth Equals In-Person Care Quality for Diabetes Patients
A University of Florida study shows that people with diabetes who use telehealth report similar quality of care as those who see doctors in person. The study highlights that telehealth became popular during the COVID-19 pandemic and recommends its continued use in diabetes care.
Young-Rock Hong, Ph.D., M.P.H., led the study. He is an assistant professor at the UF College of Public Health and Health Professions. Hong stated that many patients and providers found telehealth convenient and effective for managing diabetes.
The expansion of telehealth access and reimbursement during the pandemic was significant. However, many of these benefits will end after the COVID-19 public health emergency concludes on December 31, 2024. Without further action, telehealth access may become limited.
What are the benefits of telehealth for diabetes management according to Dr. Young-Rock Hong’s research?
Interview with Dr. Young-Rock Hong on Telehealth and Diabetes Care
Published on NewsDirectory3.com
Interviewer: Thank you, Dr. Hong, for joining us today. Your recent study from the University of Florida reveals some compelling insights about telehealth and diabetes management. Can you summarize the key findings of your research?
Dr. Hong: Thank you for having me. Our study found that patients with diabetes who utilize telehealth report a quality of care comparable to those who see their doctors in person. This was particularly noteworthy considering the rapid shift to telehealth during the COVID-19 pandemic, which many patients and providers embraced for its convenience and effectiveness.
Interviewer: Given the context of the pandemic, do you think the surge in telehealth usage is going to have a lasting impact on diabetes care?
Dr. Hong: Absolutely. The pandemic significantly expanded telehealth access and reimbursement options, which has been beneficial for many patients. Our study suggests that integrating telehealth into diabetes management can help maintain the quality of care and foster patient trust. However, we must be cautious, as many of these pandemic-era benefits may end after the public health emergency concludes on December 31, 2024, unless further legislative action is taken.
Interviewer: That’s an important point. What specific recommendations does your study make for the future of telehealth in diabetes care?
Dr. Hong: We recommend that healthcare systems and policymakers prioritize the ongoing integration of telehealth into diabetes management. This includes considering compensatory structures for remote visits and ensuring that patients continue to have reliable access to telehealth services. Our goal is to preserve the convenience and accessibility that many patients have found invaluable during the pandemic.
Interviewer: How have patient attitudes towards telehealth shifted due to their experiences during the pandemic?
Dr. Hong: Many patients have reported a favorable shift in attitude toward telehealth. They appreciate the reduced travel time and increased flexibility in scheduling appointments. Our findings highlight that this convenience does not compromise the perceived quality of care, and in some cases, it may enhance adherence to management plans for diabetes.
Interviewer: Looking ahead, do you foresee any challenges that might hinder the continued use of telehealth in diabetes management?
Dr. Hong: Yes, there are several challenges. One of the biggest obstacles is the potential reversal of expanded access to telehealth once the public health emergency ends. Without proper legislation to sustain these services, patients may find themselves without the care options they’ve come to rely on. Additionally, there are concerns regarding digital literacy and access to necessary technology among some patient populations.
Interviewer: Thank you for shedding light on these critical aspects, Dr. Hong. Any final thoughts on the role of telehealth in managing chronic conditions like diabetes?
Dr. Hong: It’s essential that we recognize telehealth as a valuable tool in managing chronic illnesses, including diabetes. By continuing to embrace and expand telehealth options, we can ensure that all patients receive consistent and high-quality care, which ultimately leads to better health outcomes.
Interviewer: Thank you, Dr. Hong, for your insights and for the important work you’re doing in this field.
Dr. Hong: Thank you for the opportunity. It’s vital to keep the conversation going about how we can improve diabetes care in our rapidly evolving healthcare landscape.
Overall, the study promotes the ongoing integration of telehealth in diabetes management to maintain quality care and patient trust.
